Are There Differences in the Treatment Strategies and Outcomes Between High-Risk Multiple Myeloma Patients and Those With Low-Risk Disease and Without Comorbities?. Hematol Meeting Rep 2009, 2 (7). https://doi.org/10.4081/hmr.v2i7.407.